FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2172016368> ?p ?o ?g. }

• W2172016368 endingPage "767" @default.
• W2172016368 startingPage "760" @default.
• W2172016368 abstract "Skeletal muscle insulin resistance plays a key role in the pathogenesis of type 2 diabetes. It recently has been hypothesized that excessive activity of the inhibitor of κB (IκB)/nuclear factor κB (NFκB) inflammatory pathway is a mechanism underlying skeletal muscle insulin resistance. However, it is not known whether IκB/NFκB signaling in muscle from subjects with type 2 diabetes is abnormal. We studied IκB/NFκB signaling in vastus lateralis muscle from six subjects with type 2 diabetes and eight matched control subjects. Muscle from type 2 diabetic subjects was characterized by a 60% decrease in IκBβ protein abundance, an indicator of increased activation of the IκB/NFκB pathway. IκBβ abundance directly correlated with insulin-mediated glucose disposal (Rd) during a hyperinsulinemic (40 mU · m−2 · min−1)-euglycemic clamp (r = 0.63, P = 0.01), indicating that increased IκB/NFκB pathway activity is associated with muscle insulin resistance. We also investigated whether reversal of this abnormality could be a mechanism by which training improves insulin sensitivity. In control subjects, 8 weeks of aerobic exercise training caused a 50% increase in both IκBα and IκBβ protein. In subjects with type 2 diabetes, training increased IκBα and IκBβ protein to levels comparable with that of control subjects, and these increments were accompanied by a 40% decrease in tumor necrosis factor α muscle content and a 37% increase in insulin-stimulated glucose disposal. In summary, subjects with type 2 diabetes have reduced IκB protein abundance in muscle, suggesting excessive activity of the IκB/NFκB pathway. Moreover, this abnormality is reversed by exercise training." @default.
• W2172016368 created "2016-06-24" @default.
• W2172016368 creator A5007985329 @default.
• W2172016368 creator A5013049429 @default.
• W2172016368 creator A5015937048 @default.
• W2172016368 creator A5034471398 @default.
• W2172016368 creator A5046249009 @default.
• W2172016368 creator A5050588067 @default.
• W2172016368 creator A5089720468 @default.
• W2172016368 creator A5091912602 @default.
• W2172016368 date "2006-03-01" @default.
• W2172016368 modified "2023-10-02" @default.
• W2172016368 title "Reduced Skeletal Muscle Inhibitor of κBβ Content Is Associated With Insulin Resistance in Subjects With Type 2 Diabetes" @default.
• W2172016368 cites W1505106993 @default.
• W2172016368 cites W1776131825 @default.
• W2172016368 cites W1970306975 @default.
• W2172016368 cites W1971822868 @default.
• W2172016368 cites W1973170858 @default.
• W2172016368 cites W1985534077 @default.
• W2172016368 cites W1998221258 @default.
• W2172016368 cites W1999881028 @default.
• W2172016368 cites W2003755391 @default.
• W2172016368 cites W2011210301 @default.
• W2172016368 cites W2018903615 @default.
• W2172016368 cites W2023268846 @default.
• W2172016368 cites W2023561026 @default.
• W2172016368 cites W2025470394 @default.
• W2172016368 cites W2031637294 @default.
• W2172016368 cites W2040895935 @default.
• W2172016368 cites W2043389111 @default.
• W2172016368 cites W2048473455 @default.
• W2172016368 cites W2048718359 @default.
• W2172016368 cites W2058714321 @default.
• W2172016368 cites W2059983531 @default.
• W2172016368 cites W2071655334 @default.
• W2172016368 cites W2074860444 @default.
• W2172016368 cites W2079307376 @default.
• W2172016368 cites W2083990676 @default.
• W2172016368 cites W2095019663 @default.
• W2172016368 cites W2097838137 @default.
• W2172016368 cites W2107761594 @default.
• W2172016368 cites W2108462699 @default.
• W2172016368 cites W2108683990 @default.
• W2172016368 cites W2112123532 @default.
• W2172016368 cites W2120852510 @default.
• W2172016368 cites W2123946088 @default.
• W2172016368 cites W2124232607 @default.
• W2172016368 cites W2126317966 @default.
• W2172016368 cites W2127808488 @default.
• W2172016368 cites W2133290655 @default.
• W2172016368 cites W2140634444 @default.
• W2172016368 cites W2142031401 @default.
• W2172016368 cites W2147612813 @default.
• W2172016368 cites W2147993424 @default.
• W2172016368 cites W2148700883 @default.
• W2172016368 cites W2152211462 @default.
• W2172016368 cites W2156696618 @default.
• W2172016368 cites W2157037423 @default.
• W2172016368 cites W2162493104 @default.
• W2172016368 cites W2164641915 @default.
• W2172016368 cites W2168502383 @default.
• W2172016368 cites W2172039605 @default.
• W2172016368 cites W2331176038 @default.
• W2172016368 cites W2421037982 @default.
• W2172016368 cites W4240611973 @default.
• W2172016368 cites W4246592598 @default.
• W2172016368 doi "https://doi.org/10.2337/diabetes.55.03.06.db05-0677" @default.
• W2172016368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16505240" @default.
• W2172016368 hasPublicationYear "2006" @default.
• W2172016368 type Work @default.
• W2172016368 sameAs 2172016368 @default.
• W2172016368 citedByCount "134" @default.
• W2172016368 countsByYear W21720163682012 @default.
• W2172016368 countsByYear W21720163682013 @default.
• W2172016368 countsByYear W21720163682014 @default.
• W2172016368 countsByYear W21720163682015 @default.
• W2172016368 countsByYear W21720163682016 @default.
• W2172016368 countsByYear W21720163682017 @default.
• W2172016368 countsByYear W21720163682018 @default.
• W2172016368 countsByYear W21720163682019 @default.
• W2172016368 countsByYear W21720163682020 @default.
• W2172016368 countsByYear W21720163682021 @default.
• W2172016368 countsByYear W21720163682022 @default.
• W2172016368 countsByYear W21720163682023 @default.
• W2172016368 crossrefType "journal-article" @default.
• W2172016368 hasAuthorship W2172016368A5007985329 @default.
• W2172016368 hasAuthorship W2172016368A5013049429 @default.
• W2172016368 hasAuthorship W2172016368A5015937048 @default.
• W2172016368 hasAuthorship W2172016368A5034471398 @default.
• W2172016368 hasAuthorship W2172016368A5046249009 @default.
• W2172016368 hasAuthorship W2172016368A5050588067 @default.
• W2172016368 hasAuthorship W2172016368A5089720468 @default.
• W2172016368 hasAuthorship W2172016368A5091912602 @default.
• W2172016368 hasBestOaLocation W21720163681 @default.
• W2172016368 hasConcept C126322002 @default.
• W2172016368 hasConcept C134018914 @default.
• W2172016368 hasConcept C2777180221 @default.
• W2172016368 hasConcept C2777391703 @default.

• next